Organon & Co.
OGN
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzysā¦ read more
Healthcare
Drug ManufacturersāGeneral
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.64
Price+0.07%
$0.01
1Y
Price
Market Cap
$3.582b
Mid
Price/Earnings 3y Avg5y Avg
4.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+23.8%
EBITDA Margin+6.9%
Net Profit Margin+4.2%
Free Cash Flow Margin+23.8%
EBITDA Margin+6.9%
Net Profit Margin+4.2%
Free Cash Flow MarginRevenue
$6.127b
-1.4%
1y CAGR-0.7%
3y CAGR-0.2%
5y CAGREarnings
$209m
+11.8%
1y CAGR-27.4%
3y CAGR-17.6%
5y CAGREPS
$0.77
+6.9%
1y CAGR-29.3%
3y CAGR-19.2%
5y CAGRBook Value
$1.006b
$13.178b
Assets$12.172b
Liabilities$8.553b
DebtDebt to Assets
64.9%
6.5x
Debt to EBITDAFree Cash Flow
$498m
-7.4%
1y CAGR-2.2%
3y CAGR+4.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company